Baxter International Inc. (NYSE:BAX) Shares Sold by Trust Co. of Toledo NA OH

Trust Co. of Toledo NA OH lowered its holdings in shares of Baxter International Inc. (NYSE:BAX) by 23.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,443 shares of the medical instruments supplier’s stock after selling 4,470 shares during the period. Trust Co. of Toledo NA OH’s holdings in Baxter International were worth $421,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in BAX. Coho Partners Ltd. acquired a new position in Baxter International during the third quarter worth about $57,229,000. Shapiro Capital Management LLC raised its position in Baxter International by 19.7% during the second quarter. Shapiro Capital Management LLC now owns 3,285,048 shares of the medical instruments supplier’s stock worth $109,885,000 after acquiring an additional 541,575 shares during the last quarter. National Pension Service raised its position in Baxter International by 22.1% during the third quarter. National Pension Service now owns 1,154,616 shares of the medical instruments supplier’s stock worth $43,841,000 after acquiring an additional 208,726 shares during the last quarter. Geode Capital Management LLC raised its position in Baxter International by 1.4% during the third quarter. Geode Capital Management LLC now owns 12,156,660 shares of the medical instruments supplier’s stock worth $460,022,000 after acquiring an additional 170,776 shares during the last quarter. Finally, Sivik Global Healthcare LLC grew its holdings in shares of Baxter International by 50.0% during the third quarter. Sivik Global Healthcare LLC now owns 150,000 shares of the medical instruments supplier’s stock worth $5,696,000 after buying an additional 50,000 shares in the last quarter. Institutional investors and hedge funds own 90.19% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on BAX shares. Stifel Nicolaus lowered their price target on shares of Baxter International from $46.00 to $38.00 and set a “buy” rating for the company in a report on Monday, November 11th. StockNews.com downgraded shares of Baxter International from a “buy” rating to a “hold” rating in a report on Monday, November 11th. Finally, Citigroup lowered their price target on shares of Baxter International from $37.00 to $35.00 and set a “neutral” rating for the company in a report on Wednesday, December 11th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $40.45.

Baxter International Price Performance

Baxter International stock opened at $30.46 on Tuesday. Baxter International Inc. has a 1 year low of $28.33 and a 1 year high of $44.01. The firm has a 50 day moving average price of $31.47 and a 200 day moving average price of $34.78. The company has a market cap of $15.55 billion, a price-to-earnings ratio of 152.31, a PEG ratio of 12.74 and a beta of 0.59. The company has a debt-to-equity ratio of 1.31, a quick ratio of 1.09 and a current ratio of 1.43.

Baxter International (NYSE:BAX) last released its quarterly earnings data on Friday, November 8th. The medical instruments supplier reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.78 by $0.02. Baxter International had a net margin of 0.77% and a return on equity of 18.30%. The company had revenue of $3.85 billion during the quarter, compared to the consensus estimate of $3.85 billion. During the same period in the previous year, the firm earned $0.68 earnings per share. Baxter International’s revenue for the quarter was up 3.8% on a year-over-year basis. Sell-side analysts predict that Baxter International Inc. will post 1.92 earnings per share for the current year.

Baxter International Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th were given a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 2.23%. The ex-dividend date of this dividend was Friday, November 29th. Baxter International’s payout ratio is currently 340.00%.

Baxter International Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.